Correlation Between Neuroone Medical and Neuropace

Can any of the company-specific risk be diversified away by investing in both Neuroone Medical and Neuropace at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Neuroone Medical and Neuropace into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Neuroone Medical Technologies and Neuropace, you can compare the effects of market volatilities on Neuroone Medical and Neuropace and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Neuroone Medical with a short position of Neuropace. Check out your portfolio center. Please also check ongoing floating volatility patterns of Neuroone Medical and Neuropace.

Diversification Opportunities for Neuroone Medical and Neuropace

-0.86

Correlation Coefficient

Neuroone Medical  Neuropace

Pay attention - limited upside

The 3 months correlation between Neuroone and Neuropace is -0.86. Overlapping area represents the amount of risk that can be diversified away by holding Neuroone Medical Technologies and Neuropace in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Neuropace and Neuroone Medical is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Neuroone Medical Technologies are associated (or correlated) with Neuropace. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Neuropace has no effect on the direction of Neuroone Medical i.e., Neuroone Medical and Neuropace go up and down completely randomly.

Pair Corralation between Neuroone Medical and Neuropace

Given the investment horizon of 90 days Neuroone Medical is expected to generate 13.84 times less return on investment than Neuropace. But when comparing it to its historical volatility, Neuroone Medical Technologies is 1.01 times less risky than Neuropace. It trades about 0.01 of its potential returns per unit of risk. Neuropace is currently generating about 0.1 of returns per unit of risk over similar time horizon. If you would invest  144.00  in Neuropace on September 22, 2024 and sell it today you would earn a total of  1,009  from holding Neuropace or generate 700.69% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Significant
Accuracy	100.0%
Values	Daily Returns

Neuroone Medical Technologies  vs.  Neuropace

Neuroone Medical Tec

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Neuroone Medical Technologies has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of latest unfluctuating performance, the Stock's basic indicators remain sound and the latest tumult on Wall Street may also be a sign of longer-term gains for the firm shareholders.

Neuropace

Risk-Adjusted Performance

12 of 100

Good

Compared to the overall equity markets, risk-adjusted returns on investments in Neuropace are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of rather inconsistent fundamental indicators, Neuropace exhibited solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Neuroone Medical and Neuropace

The main advantage of trading using opposite Neuroone Medical and Neuropace positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Neuroone Medical position performs unexpectedly, Neuropace can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Neuropace will offset losses from the drop in Neuropace's long position.

The idea behind Neuroone Medical Technologies and Neuropace pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.